CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas will serve on the International Finance Panel at BioContact 2007 on October 3, 2007 in Quebec City
News | 10. 03. 2007
